Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables - Other: 2020-2024

Historic Receivables - Other for Bicycle Therapeutics (BCYC) over the last 5 years, with Dec 2024 value amounting to $35.7 million.

  • Bicycle Therapeutics' Receivables - Other rose 16.03% to $67.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.3 million, marking a year-over-year increase of 16.03%. This contributed to the annual value of $35.7 million for FY2024, which is 48.31% up from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Receivables - Other is $35.7 million, which was up 48.31% from $24.0 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Receivables - Other peaked at $35.7 million during FY2024, and registered a low of $9.2 million during FY2020.
  • Its 3-year average for Receivables - Other is $26.3 million, with a median of $24.0 million in 2023.
  • Data for Bicycle Therapeutics' Receivables - Other shows a peak YoY spiked of 75.64% (in 2022) over the last 5 years.
  • Over the past 5 years, Bicycle Therapeutics' Receivables - Other (Yearly) stood at $9.2 million in 2020, then grew by 18.88% to $10.9 million in 2021, then soared by 75.64% to $19.2 million in 2022, then climbed by 25.45% to $24.0 million in 2023, then spiked by 48.31% to $35.7 million in 2024.